|
|
Volumn 1, Issue 2, 2006, Pages 113-118
|
|
Monoclonal antibodies against epidermal growth factor receptor in advanced colorectal carcinoma: clinical efficacy and markers of sensitivity.
a
a
HOSPITAL CLÍNIC
(Spain)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
IMMUNOLOGIC FACTOR;
MONOCLONAL ANTIBODY;
PHARMACOLOGICAL BIOMARKER;
ANIMAL;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
DRUG RESISTANCE;
GENETICS;
HUMAN;
REVIEW;
ANIMALS;
ANTIBODIES, MONOCLONAL;
BIOMARKERS, PHARMACOLOGICAL;
COLORECTAL NEOPLASMS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
IMMUNOLOGIC FACTORS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 45549102231
PISSN: 15748871
EISSN: None
Source Type: Journal
DOI: 10.2174/157488706776876463 Document Type: Review |
|
Times cited : (3)
|
|
References (65)
|
